Transaortic mitral valve secondary chordal cutting in patients with obstructive hypertrophic cardiomyopathy and mild septal hypertrophy.
نویسندگان
چکیده
A proportion of patients with obstructive hypertrophic cardiomyopathy (HCM) and severe heart failure symptoms have only mild septal hypertrophy (1). In such patients, mitral valve (MV) abnormalities play an important role in systolic MV leaflets displacement into the left ventricular LV outflow tract and blood flow obstruction (1-3). Therefore, conventional septal myectomy alone may not be sufficient to relieve LV obstruction and symptoms, and often MV repair or replacement is the surgical alternative (1). Transaortic cutting of MV secondary chordae is a novel technique for MV repair that, associated with a shallow septal myectomy, abolishes the outflow gradient, relieves heart failure symptoms, and avoids MV replacement in patients with obstructive HCM and mild septal thickness (4). A 45-year-old female patient with obstructive HCM, mild septal hypertrophy and severe heart failure symptoms (New York Heart Association functional class III) unresponsive to medications was referred to our institution for surgical treatment of LV outflow obstruction. Physical examination revealed blood pressure 124/72 mmHg and heart rate of 72 BPM on bisoprolol 10 mg/day. Transthoracic echocardiography showed mild septal hypertrophy (17 mm) confined mainly to the basal and medium portion of the anterior septum, with marked systolic anterior motion of the MV leaflets and leaflet-septal contact at rest, and moderate left atrial dilatation. Doppler echocardiography showed an LV outflow maximal gradient of 72 mmHg under basal conditions, moderate-to-severe MV regurgitation, and a systolic pulmonary pressure of 32 mmHg. Cardiac magnetic resonance documented a small area of intramural delayed enhancement on the anterior septum. Coronary angiography was normal. Because of severe outflow gradient and heart failure symptoms, relatively mild septal thickness, MV leaflets with anterior leaflet tenting, and important MV regurgitation, we planned a shallow surgical myectomy, possibly associated with MV secondary chordal cutting through a median sternotomy.
منابع مشابه
Evolving Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy.
D ynamic left ventricular outflow obstruction is a major cause of exertional symptoms in patients with hypertrophic cardiomyopathy. The obstruction is secondary to systolic anterior motion of the mitral valve abutting against a hypertrophied septum, resulting in diastolic dysfunction, myocardial oxygen supply-demand mismatch, reduced forward output, and secondary mitral regurgitation. Medical t...
متن کاملSevere mitral regurgitation treated by ventricular septal myectomy
Corresponding author: Fernanda Santos Silva Azinhaga das Galhardas, 181, 3oA 1600-470 Lisboa, Portugal e.mail: [email protected] A 73 year old woman with a previous diagnosis of hypertrophic obstructive cardiomyopathy (HOCM) and severe mitral regurgitation was scheduled for transaortic septal myectomy (Morrow procedure) and mitral reconstruction/replacement. After anesthesia induction,...
متن کاملLeft Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy Patients Without Severe Septal Hypertrophy: Implications of Mitral Valve and Papillary Muscle Abnormalities Assessed Using Cardiac Magnetic Resonance and Echocardiography.
BACKGROUND In patients with hypertrophic cardiomyopathy and left ventricular outflow tract (LVOT) obstruction, but without basal septal hypertrophy, we sought to identify mitral valve (MV) and papillary muscle (PM) abnormalities that predisposed to LVOT obstruction, using echo and cardiac magnetic resonance. METHODS AND RESULTS We studied 121 patients with hypertrophic cardiomyopathy hypertro...
متن کاملMinimally Invasive Trans-Mitral Septal Myectomy to Treat Hypertrophic Obstructive Cardiomyopathy
A 43-year-old man with symptomatic hypertrophic obstructive cardiomyopathy (HOCM) was admitted to our hospital with aggravated exertional dyspnea and successfully treated with robotic transmitral septal myectomy. Minimally invasive transmitral septal myectomy may be a feasible surgical option for the treatment of HOCM in selected cases as an alternative to transaortic myectomy.
متن کاملThrough Thick and Thin
Patients with symptoms caused by hypertrophic obstructive cardiomyopathy are treated with β-blockers, verapamil, and disopyramide. Novel drugs are under development. The minority of patients whose symptoms interfere substantially with lifestyle despite optimal pharmacological management may be offered septal reduction therapy with ablation or myectomy. Other mechanical therapies, including shor...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Annals of cardiothoracic surgery
دوره 6 4 شماره
صفحات -
تاریخ انتشار 2017